But also levels of synaptopodin, synaptophysin, synaptotagmins, neurogranin and GAP43 were lower in patients with Alzheimer's disease than in cognitively normal controls. This evidence concerns the gene SYNPO and early-onset autosomal dominant Alzheimer disease.